Tenon Medical (TNON) Stock Price, News & Analysis

Company Overview

Tenon Medical, Inc. is a development-stage medical device company focused on the research, development and commercialization of next-generation surgical biologic adhesives and sealants. The company’s proprietary platform is designed to create tissue-compatible adhesives that can serve as alternatives or complements to traditional sutures and staples, with the goal of improving surgical efficiency, reducing postoperative complications and enhancing patient outcomes.

Tenon Medical’s product pipeline centers on protein-based polymer formulations that cross-link in situ to form a flexible, yet durable, bond with native tissue. Lead indications under investigation include soft tissue repair in general and vascular surgery, hernia reinforcement and leak prevention in gastrointestinal procedures. The company advances its candidates through preclinical studies and early-stage clinical evaluations while working with contract manufacturing organizations to scale production in anticipation of regulatory submissions.

Incorporated in 2012, Tenon Medical is led by a management team with backgrounds in medical device innovation, regulatory affairs and commercial development. Headquartered in the United States, the company maintains collaborations with academic institutions and strategic partners to accelerate its development programs. Tenon Medical’s shares trade on the NASDAQ under the ticker symbol TNON.

Key Stats

• Today's Range: $1.13 to $1.22
• 50-Day Range: $1.01 to $1.67
• 52-Week Range: $0.85 to $7.51
• Volume: 265,302 shs
• Average Volume: 4.20 million shs
• Market Capitalization: $10.35 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: $5.50
• Consensus Rating: Buy

Tenon Medical Stock Analysis - MarketRank™

Tenon Medical scored higher than 42% of companies evaluated by MarketBeat, and ranked 732nd out of 960 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 3.5 / 5
• Analyst Rating: Buy

Consensus Rating

Tenon Medical has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 3 buy ratings, no hold ratings, and no sell ratings.

Upside Potential

Tenon Medical has a consensus price target of $5.50, representing about 372.1% upside from its current price of $1.17.

Amount of Analyst Coverage

Tenon Medical has received no research coverage in the past 90 days.

Earnings and Valuation

• Score: 0.0 / 5
• Proj. Earnings Growth: N/A

Price to Earnings Ratio vs. the Market

The P/E ratio of Tenon Medical is -0.04, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of Tenon Medical is -0.04, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Book Value per Share Ratio

Tenon Medical has a P/B Ratio of 1.64. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

Short Interest

• Score: 4.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

12.01% of the float of Tenon Medical has been sold short.

Short Interest Ratio / Days to Cover

Tenon Medical has a short interest ratio ("days to cover") of 0.1, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Tenon Medical has recently decreased by 46.51%, indicating that investor sentiment is improving significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Tenon Medical does not currently pay a dividend.

Dividend Growth

Tenon Medical does not have a long track record of dividend growth.

Sustainability and ESG

• Score: N/A
• Environmental Score: N/A

Percentage of Shares Shorted

12.01% of the float of Tenon Medical has been sold short.

Short Interest Ratio / Days to Cover

Tenon Medical has a short interest ratio ("days to cover") of 0.1, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Tenon Medical has recently decreased by 46.51%, indicating that investor sentiment is improving significantly.

News and Social Media

• Score: 3.0 / 5
• News Sentiment: 1.45

News Sentiment

Tenon Medical has a news sentiment score of 1.45. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.92 average news sentiment score of Medical companies.

News Coverage This Week

MarketBeat has tracked 2 news articles for Tenon Medical this week, compared to 1 article on an average week.

Search Interest

Only 2 people have searched for TNON on MarketBeat in the last 30 days. This is a decrease of -71% compared to the previous 30 days.

MarketBeat Follows

Only 1 people have added Tenon Medical to their MarketBeat watchlist in the last 30 days. This is a decrease of -80% compared to the previous 30 days.

Company Ownership

• Score: 0.0 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Tenon Medical insiders have not sold or bought any company stock.

Percentage Held by Insiders

Only 0.33% of the stock of Tenon Medical is held by insiders.

Percentage Held by Institutions

Only 22.74% of the stock of Tenon Medical is held by institutions.

TNON Stock Analysis - Frequently Asked Questions

How have TNON shares performed this year?

Tenon Medical's stock was trading at $1.88 at the start of the year. Since then, TNON stock has decreased by 38.0% and is now trading at $1.1650.

How were Tenon Medical's earnings last quarter?

Tenon Medical, Inc. (NASDAQ:TNON) issued its quarterly earnings results on Wednesday, August, 13th. The company reported ($0.36) earnings per share for the quarter, beating analysts' consensus estimates of ($0.47) by $0.11. The firm earned $0.56 million during the quarter, compared to the consensus estimate of $0.91 million. Tenon Medical had a negative trailing twelve-month return on equity of 332.11% and a negative net margin of 429.45%.
Read the conference call transcript.

When did Tenon Medical IPO?

Tenon Medical (TNON) raised $16 million in an initial public offering on Wednesday, April 27th 2022. The company issued 3,200,000 shares at $4.50-$5.50 per share.

Who are Tenon Medical's major shareholders?

Tenon Medical's top institutional investors include SBI Securities Co. Ltd. (0.52%). Insiders that own company stock include Dick Steven M Van, Richard Ginn and Steven M Foster.
View institutional ownership trends.

How do I buy shares of Tenon Medical?

Shares of TNON stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Tenon Medical own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Tenon Medical investors own include Ardelyx (ARDX), Broadcom (AVGO), CrowdStrike (CRWD), First Financial Bankshares (FFIN), Eli Lilly and Company (LLY) and Meta Platforms (META).

Company Calendar

• Last Earnings: 8/13/2025
• Today: 9/16/2025
• Next Earnings (Estimated): 11/11/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: MED INSTRUMENTS
• Sub-Industry: Medical Equipment
• Current Symbol: NASDAQ:TNON
• CIK: 1560293
• Web: www.tenonmed.com
• Phone: 408-649-5760
• Fax: N/A
• Employees: 8
• Year Founded: N/A

Price Target and Rating

• Average Price Target for Tenon Medical: $5.50
• High Price Target: $8.00
• Low Price Target: $3.00
• Potential Upside/Downside: +378.3%
• Consensus Rating: Buy
• Rating Score (0-4): 3.00
• Research Coverage: 3 Analysts

Profitability

• EPS (Trailing Twelve Months): ($27.23)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -$13.67 million
• Net Margins: -429.45%
• Pretax Margin: -429.45%
• Return on Equity: -332.11%
• Return on Assets: -106.82%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 3.86
• Quick Ratio: 3.59

Sales & Book Value

• Annual Sales: $3.28 million
• Price / Sales: 3.11
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: $0.71 per share
• Price / Book: 1.62

Miscellaneous

• Outstanding Shares: 8,880,000
• Free Float: 8,850,000
• Market Cap: $10.21 million
• Optionable: Not Optionable
• Beta: 1.25